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Background: Myocardial infarction results in both core- & peri-infarct zones. Establishing a reproducible, chronic infarct model in a large animal 
is critical for pre-clinical studies that target these zones. We tested whether 1-hour porcine ischemia-reperfusion (IR) generates a reproducible 
ischemic cardiomyopathy, using MRI measures of infarct, injury, and area-at-risk (AAR) scores.
methods: Adult Yorkshire (n=15) & Yucatan (n=7) pigs underwent 1-hour mid-left anterior descending coronary IR. Serial cardiac MRI was 
performed at baseline (n=22), week 1 (n=14), 4 (n=8), and 12 (n=6) post-IR, for ejection fraction (EF), left ventricular end-diastolic volume (EDV), 
delayed gadolinium enhancement MRI (DEMRI) scar (4-5 standard deviations (SDs) above mean, Osirix) and injury (2-3 SDs) volumes, and T2-
weighted MRI for myocardial edema. TTC staining for AAR and scar volume was also performed.
results: EFs were reduced at week 1, but stabilized from 4 to 12 weeks (Fig 1A). EDV increases showed a similar plateau, and a reduction in %scar 
and %injury occurred only between 1 and 4 weeks (Fig 1B). DEMRI-derived injury % correlated with TTC AAR (1C,D). Preliminary T2-weighted edema 
imaging at week 1 (n=3) matched regions of TTC AAR & MRI-derived injury (1E,F).
conclusions: This 1-hour porcine IR injury model is a reproducible, chronic ischemic cardiomyopathy model for testing pre-clinical diagnostic and 
therapeutic strategies.
 
